Improving the production of components for PET imaging in cancer patients.
Establishing industrial production of components that enable expanding accessibility of PET imaging to cancer patient population.
This study is working on a new way to make special plates used in PET scans, which help doctors diagnose and treat cancer, so that they can produce them more reliably and safely for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Trace-Ability, INC. NIH-funded |
| Lab location | 1 site (Van Nuys, United States) |
| Project ID | NIH-10831090 on NIH RePORTER |
What this research studies
This research focuses on developing a new manufacturing process for Tracer-QC analysis plates used in PET imaging, which is crucial for cancer diagnosis and treatment. By utilizing high-precision injection molding, the project aims to create a scalable and consistent production method that reduces variability and contamination risks associated with current manufacturing techniques. This will ensure that high-quality kits are available for the entire PET industry, ultimately enhancing the accessibility of PET imaging for cancer patients. The study involves collaboration with Agilent Technologies to validate existing assays in the newly produced plates.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research are cancer patients who require PET imaging for diagnosis or treatment monitoring.
Not a fit: Patients who do not require PET imaging or those with conditions that do not involve cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the availability and reliability of PET imaging for cancer patients, leading to better diagnostic and treatment outcomes.
How similar studies have performed: Similar approaches in enhancing manufacturing processes for medical imaging components have shown promise, indicating potential for success in this novel application.
Where this research is happening
Van Nuys, United States
- Trace-Ability, INC. — Van Nuys, United States (Active)
Researchers
- Principal investigator: Elizarov, Arkadij — Trace-Ability, INC.
- Study coordinator: Elizarov, Arkadij
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.